The novel iron chelator, DIBI, attenuates inflammation and improves outcome in colon ascendens stent peritonitis-induced experimental sepsis.

CONCLUSIONS: DIBI has promising potential for sepsis treatment including its use as a sole or an adjunct therapeutic with antibiotics. PMID: 32925011 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32925011?dopt=Abstract

Source: Clinical Hemorheology and Microcirculation - September 6, 2020 Category: Hematology Authors: Fokam D, Aali M, Dickson K, Scott C, Holbein B, Zhou J, Lehmann C Tags: Clin Hemorheol Microcirc Source Type: research